BIOMAT Database Logo BIOMAT Database Logo

Leveraging Lessons Learned from Yellow Fever and Polio Immunization Campaigns during COVID-19 Pandemic, Ghana, 2021. 2022

Kwame Amponsa-Achiano, and Joseph Asamoah Frimpong, and Danielle Barradas, and Delia Akosua Bandoh, and Ernest Kenu

Ghana is a yellow fever-endemic country and experienced a vaccine-derived polio outbreak in July 2019. A reactive polio vaccination campaign was conducted in September 2019 and preventive yellow fever campaign in November 2020. On March 12, 2020, Ghana confirmed its first COVID-19 cases. During February-August 2021, Ghana received 1,515,450 COVID-19 vaccines through the COVID-19 Vaccines Global Access initiative and other donor agencies. We describe how systems and infrastructure used for polio and yellow fever vaccine deployment and the lessons learned in those campaigns were used to deploy COVID-19 vaccines. During March-August 2021, a total of 1,424,008 vaccine doses were administered in Ghana. By using existing vaccination and health systems, officials in Ghana were able to deploy COVID-19 vaccines within a few months with <5% vaccine wastage and minimal additional resources despite the short shelf-life of vaccines received. These strategies were essential in saving lives in a resource-limited country.

UI MeSH Term Description Entries
D011051 Poliomyelitis An acute infectious disease of humans, particularly children, caused by any of three serotypes of human poliovirus (POLIOVIRUS). Usually the infection is limited to the gastrointestinal tract and nasopharynx, and is often asymptomatic. The central nervous system, primarily the spinal cord, may be affected, leading to rapidly progressive paralysis, coarse FASCICULATION and hyporeflexia. Motor neurons are primarily affected. Encephalitis may also occur. The virus replicates in the nervous system, and may cause significant neuronal loss, most notably in the spinal cord. A rare related condition, nonpoliovirus poliomyelitis, may result from infections with nonpoliovirus enteroviruses. (From Adams et al., Principles of Neurology, 6th ed, pp764-5) Infantile Paralysis,Polio,Poliomyelitis, Nonpoliovirus,Poliomyelitis, Preparalytic,Encephalitis, Polio,Epidemic Acute Poliomyelitis,Polio Encephalitis,Poliomyelitis Infection,Poliomyelitis, Acute,Acute Poliomyelitis,Acute Poliomyelitis, Epidemic,Infection, Poliomyelitis,Infections, Poliomyelitis,Nonpoliovirus Poliomyelitis,Paralysis, Infantile,Poliomyelitides, Preparalytic,Poliomyelitis Infections,Poliomyelitis, Epidemic Acute,Polios,Preparalytic Poliomyelitis
D005869 Ghana A republic in western Africa, south of BURKINA FASO and west of TOGO. Its capital is Accra. Gold Coast,Republic of Ghana
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000086382 COVID-19 A viral disorder generally characterized by high FEVER; COUGH; DYSPNEA; CHILLS; PERSISTENT TREMOR; MUSCLE PAIN; HEADACHE; SORE THROAT; a new loss of taste and/or smell (see AGEUSIA and ANOSMIA) and other symptoms of a VIRAL PNEUMONIA. In severe cases, a myriad of coagulopathy associated symptoms often correlating with COVID-19 severity is seen (e.g., BLOOD COAGULATION; THROMBOSIS; ACUTE RESPIRATORY DISTRESS SYNDROME; SEIZURES; HEART ATTACK; STROKE; multiple CEREBRAL INFARCTIONS; KIDNEY FAILURE; catastrophic ANTIPHOSPHOLIPID ANTIBODY SYNDROME and/or DISSEMINATED INTRAVASCULAR COAGULATION). In younger patients, rare inflammatory syndromes are sometimes associated with COVID-19 (e.g., atypical KAWASAKI SYNDROME; TOXIC SHOCK SYNDROME; pediatric multisystem inflammatory disease; and CYTOKINE STORM SYNDROME). A coronavirus, SARS-CoV-2, in the genus BETACORONAVIRUS is the causative agent. 2019 Novel Coronavirus Disease,2019 Novel Coronavirus Infection,2019-nCoV Disease,2019-nCoV Infection,COVID-19 Pandemic,COVID-19 Pandemics,COVID-19 Virus Disease,COVID-19 Virus Infection,Coronavirus Disease 2019,Coronavirus Disease-19,SARS Coronavirus 2 Infection,SARS-CoV-2 Infection,Severe Acute Respiratory Syndrome Coronavirus 2 Infection,COVID19,2019 nCoV Disease,2019 nCoV Infection,2019-nCoV Diseases,2019-nCoV Infections,COVID 19,COVID 19 Pandemic,COVID 19 Virus Disease,COVID 19 Virus Infection,COVID-19 Virus Diseases,COVID-19 Virus Infections,Coronavirus Disease 19,Disease 2019, Coronavirus,Disease, 2019-nCoV,Disease, COVID-19 Virus,Infection, 2019-nCoV,Infection, COVID-19 Virus,Infection, SARS-CoV-2,Pandemic, COVID-19,SARS CoV 2 Infection,SARS-CoV-2 Infections,Virus Disease, COVID-19,Virus Infection, COVID-19
D000086663 COVID-19 Vaccines Vaccines or candidate vaccines containing SARS-CoV-2 component antigens, genetic materials, or inactivated SARS-CoV-2 virus, and designed to prevent COVID-19. 2019 Novel Coronavirus Vaccine,2019 Novel Coronavirus Vaccines,2019-nCoV Vaccine,2019-nCoV Vaccines,COVID 19 Vaccine,COVID-19 Vaccine,COVID-19 Virus Vaccine,COVID-19 Virus Vaccines,COVID19 Vaccine,COVID19 Vaccines,COVID19 Virus Vaccine,COVID19 Virus Vaccines,Coronavirus Disease 2019 Vaccine,Coronavirus Disease 2019 Vaccines,Coronavirus Disease 2019 Virus Vaccine,Coronavirus Disease 2019 Virus Vaccines,Coronavirus Disease-19 Vaccine,Coronavirus Disease-19 Vaccines,SARS Coronavirus 2 Vaccines,SARS-CoV-2 Vaccine,SARS-CoV-2 Vaccines,SARS2 Vaccine,SARS2 Vaccines,2019 nCoV Vaccine,2019 nCoV Vaccines,COVID 19 Vaccines,COVID 19 Virus Vaccine,COVID 19 Virus Vaccines,Coronavirus Disease 19 Vaccine,Coronavirus Disease 19 Vaccines,SARS CoV 2 Vaccine,SARS CoV 2 Vaccines,Vaccine, 2019-nCoV,Vaccine, COVID 19,Vaccine, COVID-19,Vaccine, COVID-19 Virus,Vaccine, COVID19,Vaccine, COVID19 Virus,Vaccine, Coronavirus Disease-19,Vaccine, SARS-CoV-2,Vaccine, SARS2,Vaccines, 2019-nCoV,Vaccines, COVID-19,Vaccines, COVID-19 Virus,Vaccines, COVID19,Vaccines, COVID19 Virus,Vaccines, Coronavirus Disease-19,Vaccines, SARS-CoV-2,Vaccines, SARS2,Virus Vaccine, COVID-19,Virus Vaccine, COVID19,Virus Vaccines, COVID-19,Virus Vaccines, COVID19
D014611 Vaccination Administration of vaccines to stimulate the host's immune response. This includes any preparation intended for active immunological prophylaxis. Immunization, Active,Active Immunization,Active Immunizations,Immunizations, Active,Vaccinations
D014612 Vaccines Suspensions of killed or attenuated microorganisms (bacteria, viruses, fungi, protozoa), antigenic proteins, synthetic constructs, or other bio-molecular derivatives, administered for the prevention, amelioration, or treatment of infectious and other diseases. Vaccine
D015004 Yellow Fever An acute infectious disease primarily of the tropics, caused by a virus and transmitted to man by mosquitoes of the genera Aedes and Haemagogus. The severe form is characterized by fever, HEMOLYTIC JAUNDICE, and renal damage. Fever, Yellow,Fevers, Yellow,Yellow Fevers
D017589 Immunization Programs Organized services to administer immunization procedures in the prevention of various diseases. The programs are made available over a wide range of sites: schools, hospitals, public health agencies, voluntary health agencies, etc. They are administered to an equally wide range of population groups or on various administrative levels: community, municipal, state, national, international. Vaccination Awareness,Vaccination Campaign,Vaccination Promotion,Awareness, Vaccination,Awarenesses, Vaccination,Campaign, Vaccination,Campaigns, Vaccination,Immunization Program,Program, Immunization,Programs, Immunization,Promotion, Vaccination,Promotions, Vaccination,Vaccination Awarenesses,Vaccination Campaigns,Vaccination Promotions
D058873 Pandemics Epidemics of infectious disease that have spread to many countries, often more than one continent, and usually affecting a large number of people. Pandemic

Related Publications

Kwame Amponsa-Achiano, and Joseph Asamoah Frimpong, and Danielle Barradas, and Delia Akosua Bandoh, and Ernest Kenu
Leveraging lessons learned from the COVID-19 pandemic for HIV.
January 2022, Communications medicine,
Kwame Amponsa-Achiano, and Joseph Asamoah Frimpong, and Danielle Barradas, and Delia Akosua Bandoh, and Ernest Kenu
Leveraging COVID-19 pandemic response for improved health system financing: Lessons from Ghana.
July 2022, The International journal of health planning and management,
Kwame Amponsa-Achiano, and Joseph Asamoah Frimpong, and Danielle Barradas, and Delia Akosua Bandoh, and Ernest Kenu
Lessons learned from the COVID-19 pandemic.
July 2020, Acta paediatrica (Oslo, Norway : 1992),
Kwame Amponsa-Achiano, and Joseph Asamoah Frimpong, and Danielle Barradas, and Delia Akosua Bandoh, and Ernest Kenu
Lessons learned from the COVID-19 pandemic.
May 2022, Health policy (Amsterdam, Netherlands),
Kwame Amponsa-Achiano, and Joseph Asamoah Frimpong, and Danielle Barradas, and Delia Akosua Bandoh, and Ernest Kenu
Lessons learned from Korea: COVID-19 pandemic.
July 2020, Infection control and hospital epidemiology,
Kwame Amponsa-Achiano, and Joseph Asamoah Frimpong, and Danielle Barradas, and Delia Akosua Bandoh, and Ernest Kenu
Lessons learned from the COVID-19 pandemic.
May 2022, Health policy (Amsterdam, Netherlands),
Kwame Amponsa-Achiano, and Joseph Asamoah Frimpong, and Danielle Barradas, and Delia Akosua Bandoh, and Ernest Kenu
Data curation during a pandemic and lessons learned from COVID-19.
January 2021, Nature computational science,
Kwame Amponsa-Achiano, and Joseph Asamoah Frimpong, and Danielle Barradas, and Delia Akosua Bandoh, and Ernest Kenu
NIH Considers Lessons Learned During COVID-19 Pandemic.
March 2023, JAMA,
Kwame Amponsa-Achiano, and Joseph Asamoah Frimpong, and Danielle Barradas, and Delia Akosua Bandoh, and Ernest Kenu
Lessons Learned During the COVID-19 Virus Pandemic.
June 2020, Journal of the American College of Surgeons,
Kwame Amponsa-Achiano, and Joseph Asamoah Frimpong, and Danielle Barradas, and Delia Akosua Bandoh, and Ernest Kenu
Telemedicine Lessons Learned During the COVID-19 Pandemic.
January 2022, Current allergy and asthma reports,
Copied contents to your clipboard!